ProQR Therapeutics (PRQR) Q3 2025 Earnings — Miss Estimates

Screener

Reported November 6, 2025 · Before market open

Revenue$3.4MMiss by $2.7M

EPS-$0.12Miss by $0.02

Revenue estimate$6.1M

EPS estimate-$0.10

Next report

Nov 5, 2026 (in 2 months)

Revenue estimate$4.3M

EPS estimate-$0.11

Versus estimates

Revenue

Q2 2026$10.0MBeat by $5.4M Q1 2026$2.3MMiss by $2.8M Q4 2025$5.5MMiss by $1.1M

Q3 2025$3.4MMiss by $2.7M

Q2 2025$4.5MMiss by $997.5K Q1 2025$5.0MBeat by $149.1K

Diluted EPS

Q2 2026-$0.10Beat by $0.03 Q1 2026-$0.15In line Q4 2025-$0.09Miss by $0.01

Q3 2025-$0.12Miss by $0.02

Q2 2025-$0.14Miss by $0.06 Q1 2025-$0.11Miss by $0.02

FAQ

When did ProQR Therapeutics report Q3 2025 earnings?: ProQR Therapeutics (PRQR) reported Q3 2025 earnings on November 6, 2025 before market open.
What were ProQR Therapeutics's Q3 2025 revenue and EPS?: ProQR Therapeutics reported revenue of $3.4M and eps of $-0.12 for Q3 2025.
Did ProQR Therapeutics beat estimates in Q3 2025?: Revenue missed the consensus estimate of $6.1M by $2.7M. EPS missed the consensus estimate of $-0.10 by $0.02.
How did ProQR Therapeutics's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 19.0% from $4.2M a year earlier and eps declined 9.1% from $-0.11.

Ask the moment ProQR Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk